Clinical Terapheutical Trial (TT): hidroxicloroquina, azitromicina y tocilizumab
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$871,948.8Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
PendingResearch Location
SpainLead Research Institution
Instituto de Investigación Sanitaria del hospital de la Santa Creu i Sant Pau de BarcelonaResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Clinical trial (unspecified trial phase)
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Clinical Terapheutical Trial (TT): hidroxicloroquina, azitromicina y tocilizumab